Breaking News, Financial News

Financial Report: Bristol-Myers Squibb 2Q

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb   2Q Revenues: $5.2 billion (+16%) 2Q Earnings: $764.0 million (+8%) YTD Revenues: $10.1 billion (+19%) YTD Earnings: $1.4 billion  (+2%) Comments: Pharmaceutical sales in the quarter were $4.5 billion (+16%). U.S. pharma sales were $2.6 billion (+17%) due to increased sales of Plavix, Abilify growth, and the HIV and hepatitis portfolio, as well as contributions from recent product launches, Orencia and Ixempra. Plavix sales were $1.4 billion (+17%) in the qua...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters